– UK, London – Johnson Matthey Plc (LSE:JMAT), is pleased to announce the appointment of Dr Jane Griffiths as a non-executive director of the company. Jane will join the board with effect from 1st January 2017.
Jane is currently Company Group Chairman of Janssen EMEA, the research-based pharmaceutical arm of Johnson & Johnson. She joined Johnson & Johnson in 1982 and since then has undertaken a series of roles including international and affiliate strategic marketing, sales management, product management, general management and clinical research. Jane is Chair of the Johnson & Johnson Corporate Citizenship Trust in EMEA, a sponsor of the Johnson & Johnson Women’s Leadership Initiative and a sponsor of the Janssen Global Pharmaceuticals Sustainability Council.
In addition to her roles at Janssen, Jane is past Chairwoman of the EFPIA Executive Committee, past Chairwoman of the PhRMA Europe Committee and a member of the Corporate Advisory Board of the UK Government backed ‘Your Life’ campaign which aims to encourage more young people to study STEM subjects.
Jane has a PhD in Plant Biochemistry/Genetics.
Commenting on the appointment, Tim Stevenson, Chairman of Johnson Matthey, said: “I am delighted to welcome Jane Griffiths to the board of Johnson Matthey as a non-executive director. Jane brings significant experience and understanding of the management of global businesses, particularly across the pharmaceutical sector, together with a strong interest in diversity and the encouragement of women’s careers in business”.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.